Ameriprise Financial Inc Chembio Diagnostics, Inc. Transaction History

Ameriprise Financial Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.09 - $2.55 $57,361 - $134,193	-52,625 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.06 - $5.34 $104,293 - $270,353	-50,628 Reduced 49.03%	52,625 $132,000
Q2 2021 Aug 16, 2021	SELL	$2.88 - $5.64 $57,182 - $111,982	-19,855 Reduced 16.13%	103,253 $307,000
Q1 2021 May 17, 2021	BUY	$3.4 - $7.97 $45,821 - $107,411	13,477 Added 12.29%	123,108 $432,000
Q4 2020 Feb 12, 2021	BUY	$4.11 - $7.51 $54,967 - $100,438	13,374 Added 13.89%	109,631 $521,000
Q3 2020 Nov 16, 2020	BUY	$3.28 - $5.93 $14,261 - $25,783	4,348 Added 4.73%	96,257 $467,000
Q2 2020 Aug 14, 2020	SELL	$3.18 - $15.54 $95,428 - $466,339	-30,009 Reduced 24.61%	91,909 $299,000
Q4 2019 Feb 14, 2020	BUY	$3.94 - $5.76 $26,792 - $39,168	6,800 Added 5.91%	121,918 $556,000
Q3 2019 Nov 14, 2019	BUY	$4.84 - $7.25 $51,313 - $76,864	10,602 Added 10.14%	115,118 $705,000
Q1 2019 May 15, 2019	BUY	$5.32 - $7.18 $89,721 - $121,090	16,865 Added 19.24%	104,516 $580,000
Q4 2018 Feb 14, 2019	BUY	$4.95 - $10.5 $433,872 - $920,335	87,651 New	87,651 $496,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.